Auswahl der wissenschaftlichen Literatur zum Thema „Cancer de poumon“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Cancer de poumon" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Cancer de poumon"
Chaleat, S., und L. Greillier. „Cancer du poumon“. Revue des Maladies Respiratoires Actualités 11 (Oktober 2019): S29—S35. http://dx.doi.org/10.1016/s1877-1203(19)30161-2.
Der volle Inhalt der QuelleBoucly, A., und B. Milleron. „Dépistage du cancer du poumon“. Revue des Maladies Respiratoires Actualités 6, Nr. 2 (Mai 2014): 115–17. http://dx.doi.org/10.1016/s1877-1203(14)70525-7.
Der volle Inhalt der QuelleAntoni, D., und F. Mornex. „Cancer du poumon : « Les » radiothérapies“. Revue des Maladies Respiratoires Actualités 8, Nr. 5 (September 2016): 332–40. http://dx.doi.org/10.1016/s1877-1203(16)30122-7.
Der volle Inhalt der QuelleToffart, A. C., M. Giaj Levra, L. Ferrer, J. Pinsolle, N. Terzi und D. Moro-Sibilot. „Réanimation et cancer du poumon“. Revue des Maladies Respiratoires Actualités 10, Nr. 3 (Oktober 2018): 262–68. http://dx.doi.org/10.1016/s1877-1203(18)30019-3.
Der volle Inhalt der QuelleRochon, Madeleine. „Tabagisme et cancer du poumon“. Gérontologie et société 26 / n° 105, Nr. 2 (2003): 69. http://dx.doi.org/10.3917/gs.105.0069.
Der volle Inhalt der QuelleLüthi, François, Christian Monnerat, Roger Stupp, Hans-Beat Ris, Abderrrahim Zouhair und Thomas McKee. „Cancer du poumon : portrait 2004“. Revue Médicale Suisse 62, Nr. 2477 (2004): 776–82. http://dx.doi.org/10.53738/revmed.2004.62.2477.0776.
Der volle Inhalt der QuelleMilleron, B., S. Couraud, E. Grolleau und V. Gounant. „Le dépistage du cancer du poumon“. Revue des Maladies Respiratoires Actualités 14, Nr. 2 (Oktober 2022): 2S37–2S41. http://dx.doi.org/10.1016/s1877-1203(22)00098-2.
Der volle Inhalt der QuelleGrolleau, E., M. Darrason, J. de Bermont, B. Milleron und S. Couraud. „Le dépistage du cancer du poumon“. Revue des Maladies Respiratoires Actualités 13, Nr. 2 (September 2021): 2S21–2S25. http://dx.doi.org/10.1016/s1877-1203(21)00092-6.
Der volle Inhalt der QuelleMilleron, B., V. Gounant, A. Khalil und S. Couraud. „Le dépistage du cancer du poumon“. Revue de Pneumologie Clinique 73, Nr. 1 (Februar 2017): 27–33. http://dx.doi.org/10.1016/j.pneumo.2016.10.002.
Der volle Inhalt der QuellePerez, Noemí Busquets, Berta Bernad, Javier Narváez und José Valverde. „Érythème noueux et cancer du poumon“. Revue du Rhumatisme 73, Nr. 5 (Mai 2006): 525–26. http://dx.doi.org/10.1016/j.rhum.2005.06.011.
Der volle Inhalt der QuelleDissertationen zum Thema "Cancer de poumon"
Meary, Alexandre. „Schizophrenie et cancer du poumon“. Paris 6, 2001. http://www.theses.fr/2001PA062055.
Der volle Inhalt der QuelleBenizri, Emmanuel. „HIF-1alpha : le poumon du cancer“. Nice, 2007. http://www.theses.fr/2007NICE4044.
Der volle Inhalt der QuelleAny alive organism can survive without energy, which involves a satisfactory oxygen and nutriments supply. At the initial phase of tumor progression, cells proliferate without their own vascularization ; indeed, oxygen and nutrients are delivered by simple diffusion. Nevertheless, beyond a certain size, these mechanisms are no more effective and oxygen deficiencies appear. The transcription factor HIF (Hypoxia Inducible Factor) is a key regulator required to maintain oxygen homeostasis. HIF is composed of a constitutive HIF-â sub-unit and a HIF- 1á sub-unit, specific of the hypoxic cascade. Three hifá genes have been identified : hif1a, epas 1 and hif3a that code for HIF-1á, HIF-2á and HIF-3á, respectively. Because of its ubiquitous tissue distribution and its central impact on the regulation of the target genes, HIF- 1á is the mosty studied isoform. During my laboratory training, I have contributed to 3 main projects : • First, I have been focused on the regulatory mechanisms that control HIF-1á stability and more precisely, on the study of the HIF prolyl-hydroxylase (PHDs). Using a RNA interference (RNAi) approach, we have highlighted PHD2 as the key isoform that controls HIF-1á stability in normoxia. Related to clinical studies, we have evaluated the impact of HIF-1á immunostaining in a serie of breast cancer. We have shown that HIF-1á is an independent prognostic factor and a bad preditive factor for classical adjuvant treatments. • Finally, in a pre-clinical study, we have analyzed the impact of HIF-1á invalidation by RNAi in a xenograft melanoma model. We have reported a reduction of tumor growth in mice treated with siRNAs targeting HIF-1á
Michel, Noémie. „Analyse de la contribution des kallicréines tissulaires 6 et 12 à la physiopathologie pulmonaire“. Thesis, Tours, 2013. http://www.theses.fr/2013TOUR3303/document.
Der volle Inhalt der QuelleRecently, human tissue kallikreins (KLK) emerged as a new family of serine proteases which might play a major role in the tumorigenesis. The project aims at determining the contribution of KLK6 and 12 in lung pathophysiology. We showed that ectopic KLK6 promoted A549 cell proliferation in a protease activity-dependant manner, inhibited cell apoptosis and induced β-catenin nuclear translocation. Furthermore, this study uncovered a signaling pathway mediated by KLK6 in promoting A549 cell proliferation trough activation of the PAR2-EGFR-ERK pathway.We have also identified novel substrates of KLK12, the CCN family. We reported that KLK12-mediated proteolysis of CCN1 and CCN5 can reduce or abolish the binding of VEGF, BMP2, and TGF-β1
Pardo, Olivier. „Thérapie génique du cancer du poumon par la HSP65“. Paris 5, 1997. http://www.theses.fr/1997PA05P120.
Der volle Inhalt der QuelleDerniame, Sophie. „Cancer du poumon / Réponse immunitaire locale - modulation tumeur dépendante“. Nancy 1, 2006. http://docnum.univ-lorraine.fr/public/SCD_T_2006_0097_DERNIAME.pdf.
Der volle Inhalt der QuelleLung cancer is the most frequent type of cancer in the world. Smoking is clearly the major cause of this pathology. The proliferation of tumor cells induces an inflammatory stromal reaction comprising numerous tumor-infiltrating lymphocytes. In this study, four complementary approaches have been used to study the tumor-dependent modulation of the immune system : TCR Vβ repertoire usage in flow cytometry, TCRγ gene clonal rearrangements in denaturing gradient gel electrophoresis (DGGE/TTGE), tumor and healthy lung tissue infiltration as well as lymph nodes characteristics in immunohistology and cytokine production by RNA RT-PCR. The results obtained have demonstrated the oligoclonality of T-cells in the three types of tissues tested. A Vβ13. 1 clone and a gamma clone appeared to be specifics of epidermoid carcinoma. Similarly, two TCRγ clones appeared to be restricted to adenocarcinoma. Moreover, the CD3/TCR complex was clearly down regulated in tumors compared to healthy tissue or lymph nodes. Similarly, HLA-DR, HLA-DQ and β2 microglobuline, strongly expressed on healthy pneumocytes were nearly absent from tumor cells. Several cytokines with antagonistic effects were detected within tumoral tissue, especially TGFβ and IL-10, which favour tumor growth and TNFalpha and IFNγ which potentialize the anti-tumoral immune response. In conclusion, the clones identified in healthy lung tissue could be specific of early pre-tumoral lesions induced by tobacco smoke, and some of the clones appear to be tumor-specific. However, the immune system has been defeated by several mechanisms, including a decrease of the expression of partners of the immunological synapse and the production of antagonistic cytokines
CAILLET, BRUNO. „Genetique et cancer du poumon : interet des etudes familiales“. Lyon 1, 1991. http://www.theses.fr/1991LYO1M273.
Der volle Inhalt der QuelleSève, Pascal. „Pharmacorésistance et cancer du poumon Non à petites cellules“. Lyon 1, 2006. http://www.theses.fr/2006LYO10008.
Der volle Inhalt der QuelleCauchi, Stéphane. „Etude des polymorphismes génétiques du récepteur aux hydrocarbures polycycliques aromatiques (AHR) et de son répresseur (AHRR) : relation avec l'inductibilité du CYP1A1 et le cancer pulmonaire“. Paris 5, 2003. http://www.theses.fr/2003PA05N030.
Der volle Inhalt der QuellePolycyclic aromatic hydrocarbons (PAH) found in cigarette smoke play a key role in the appearance of the lung cancer at the smokers. Cytochrome P-4501A1, metabolizes these HPA like benzo(a)pyrene in reactive and mutagen compounds. The CYP1A1 is inductible by the HPA and others compounds like dioxine. This inductibility is itself variable and largely dependent on the receptor Ah (AhR). The AhR is partially responsible for a polymorphic expression of the CYP1A1 and thus could be an important factor in carcinogenicity. We investigated the genetic polymorphisms of the AhR gene in a case-control study of lung cancer. Two new polymorphisms were found, none of them were found to play a key role. . .
RUGGIERI, SOPHIE. „Traitement des cancers du poumon non anaplasiques, non resecables, non metastatiques : a propos de 505 cas“. Angers, 1989. http://www.theses.fr/1989ANGE1084.
Der volle Inhalt der QuelleTLEMSANI, LARBI. „Prise en charge du cancer du poumon au centre hospitalier general de cahors de 1989 a 1992“. Toulouse 3, 1993. http://www.theses.fr/1993TOU31084.
Der volle Inhalt der QuelleBücher zum Thema "Cancer de poumon"
Trédaniel, Jean. Le cancer du poumon. Paris: Masson, 2004.
Den vollen Inhalt der Quelle findenLaboratoire de lutte contre la maladie (Canada). Bureau du cancer. Le cancer du poumon au Canada. Ottawa, Ont: Santé Canada, 1998.
Den vollen Inhalt der Quelle findenLitt, Claudia. J'ai le cancer, et alors? Lyon: Chronique sociale, 2012.
Den vollen Inhalt der Quelle findenGiovanni, Motta, und Agrigento International Conference on Imaging and Therapy of Lung Cancer. (1st : 1988), Hrsg. Lung cancer: Advanced concepts and present status. Genoa: Grafica, L.P., 1989.
Den vollen Inhalt der Quelle findenMackay, Bruce. Tumors of the lung. Philadelphia: W.B. Saunders, 1991.
Den vollen Inhalt der Quelle findenLemonde, Manon. Qualité de vie de personnes atteintes de cancer du poumon avancé. Montréal, Qué: Université de Montréal, 1999.
Den vollen Inhalt der Quelle findenStap, Sophie van der. La fille aux neuf perruques: Témoignage. [Paris]: Presses de la Cité, 2009.
Den vollen Inhalt der Quelle findenMayer, Carole R. Les directives avancées à l'usage des patients atteints du cancer du poumon. Sudbury, Ont: École de Service Social, Université Laurentienne, 1996.
Den vollen Inhalt der Quelle findenStatistique Canada. Direction des études analytiques. Utilisation de POHEM pour l'estimation des coûts médicaux directs associés à la pratique actuelle du traitement du cancer du poumon ainsi que pour l'évaluation économique de nouveaux traitements. Ottawa, Ont: Statistique Canada, 1997.
Den vollen Inhalt der Quelle findenNATO Advanced Research Workshop on Mechanisms in Fibre Carcinogenesis (1990 Albuquerque, N.M.). Mechanisms in fibre carcinogenesis. New York: Plenum Press, 1991.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Cancer de poumon"
Molinié, F., A. Danzon, G. Hédelin und E. A. Sauleau. „Poumon“. In Survie des patients atteints de cancer en France, 185–92. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-39310-5_25.
Der volle Inhalt der QuelleLozano, S., und J. Mazières. „Le cancer du poumon du sujet âgé“. In Oncogériatrie, 79–84. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-8178-0142-1_12.
Der volle Inhalt der QuelleDauchy, S., und C. Lopez. „Prise en charge psychologique du patient atteint de cancer du poumon“. In Oncologie thoracique, 367–78. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-287-99041-0_24.
Der volle Inhalt der QuelleSocinski, Mark A. „Cancer du poumon“. In Médecine interne de Netter, 609–16. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-70951-7.00078-5.
Der volle Inhalt der Quelle„Cancers du poumon“. In Méga Guide STAGES IFSI, 89–97. Elsevier, 2015. http://dx.doi.org/10.1016/b978-2-294-74529-4.00022-7.
Der volle Inhalt der QuelleAlexandre, J., A. Balian, L. Bensoussan, A. Chaïb, G. Gridel, K. Kinugawa, F. Lamazou et al. „Cancers du poumon“. In Le tout en un révisions IFSI, 82–89. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70633-2.50022-6.
Der volle Inhalt der QuelleALLIO, I., A. M. DEMARTINI, J. J. MENEC, V. CARDE und V. TREGUER-HERROU. „Le dépistage par le Laboratoire d’analyses, de surveillance et d’expertise de la Marine de Brest du radon, un gaz radioactif naturel en Bretagne“. In Médecine et Armées Vol. 44 No.4, 309–16. Editions des archives contemporaines, 2016. http://dx.doi.org/10.17184/eac.6820.
Der volle Inhalt der QuelleTaber, Douglass. „Alkaloid Synthesis: Crispine A (Zhou), Cermizine C (Zhang), Tangutorine (Poupon), FR901483 (Kerr), Serratezomine A (Johnston)“. In Organic Synthesis. Oxford University Press, 2011. http://dx.doi.org/10.1093/oso/9780199764549.003.0061.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Cancer de poumon"
Dias, Andrey Luis de Oliveira Gonçalves, Thaíz da Silva Gome und Leila Cristina Soares Brollo. „Câncer de endométrio associado a radiação pélvica prévia paratratamento de câncer de colo uterino: relato de caso“. In 45º Congresso da SGORJ XXIV Trocando Ideias. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/jbg-0368-1416-20211311018.
Der volle Inhalt der QuelleMacedo, Aruan Kawally Coutinho De, Felipe De Andrade Moreira, Fernanda Clara Marinheiro Oliveira und Neidivania Medeiros Da Nobrega. „O DIAGNÓSTICO PRECOCE DA LEUCEMIA MIELOIDE AGUDA“. In II Congresso Brasileiro de Hematologia Clínico-laboratorial On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/hematoclil/10.
Der volle Inhalt der Quelle